CTOs on the Move

Provectus Biopharmaceuticals

www.provectusbio.com

 
Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. Provectus` investigational oncology drug, PV-10, is an ablative immunotherapy under investigation in solid tumor cancers.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Bruce Horowitz
Chief Operating Officer Profile

Similar Companies

HNP Pharmaceuticals

HNP Pharmaceuticals is a Torrance, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MicroPort

(877) 663-7674

Cambridge Major Laboratories

Cambridge Major Laboratories is a leading global chemistry outsourcing partner to the pharmaceutical and biotechnology industries

Apexigen, Inc

Apexigen, Inc. is a privately held biopharmaceutical company discovering and developing innovative antibody therapeutics for the treatment of life-threatening and difficult-to-treat diseases. Using its proprietary antibody technology platform, Apexigen has discovered a pipeline of product candidates, which are currently at varying stages of development. The lead product candidate, APX005M, is a novel immuno-oncology antibody that stimulates and enhances an immune response against cancer. Apexigen is developing other product candidates in partnership with four leading biopharmaceutical companies in China. In addition, Apexigen has formed strategic partnerships with multi-national pharmaceutical companies, including Janssen Biotech, Alcon Laboratories and Toray Industries to discover first-in-class antibody lead candidates for the partners' programs.

DocShop Pro

DocShop Pro provides the best prices for supplies for doctors, as well as an inventory management system for practice managers. Join DocShop Pro today!